Protective cell capsules for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new way to treat type 1 diabetes by placing protective capsules containing insulin-producing cells (islets) in your body. The goal is to help your body make insulin naturally, possibly reducing the need for daily insulin shots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes, confirmed by a doctor.
- You are currently managing your diabetes with insulin (via shots or a pump).
- You are willing to receive an experimental treatment that places insulin-producing cells in your body to help control blood sugar.
- You are willing to attend frequent study visits and follow the study team's guidelines.
- Your overall health must meet the standard care guidelines at the study center.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment made from pig pancreatic cells (called OPF-310) that are placed under the skin to help control blood sugar in people with type 1 diabetes. It is for those whose diabetes is difficult to manage and who have dangerous low blood sugar episodes.
This trial tests an investigational drug that may help preserve the body's ability to make insulin in people with type 1 diabetes. It aims to slow the progression of the disease and reduce the need for insulin injections.
This Phase 1/2 study tests whether CELZ-201 is safe and can help the body keep making some of its own insulin in people who were recently diagnosed with type 1 diabetes. You may be eligible if your diabetes started within the past year and your tests show you still have some insulin-making activity.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.
This trial tests a new treatment using pancreatic cells that may help people with type 1 diabetes make insulin again. It aims to reduce severe low blood sugar episodes and improve blood sugar control.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.